Long-term investing has paid off in the case of CSL shareholders
The post If you invested $1000 in CSL (ASX:CSL) shares a decade ago, this is how much they would be worth now appeared first on The Motley Fool Australia. –
The CSL Limited (ASX: CSL) share price has been a major ASX winner over the past decade. Plus, it’s got the results to prove it.
Whereas the S&P/ASX 200 Index (ASX: XJO) has gained 83% over the past 10 years, CSL shareholders have enjoyed far healthier gains.
We’ve done the math to show you the possible benefits of long-term investing, using CSL as a case example.
Invest with a long-term horizon in mind
Biotechnology player CSL has been in the vaccines market for more than 25 years. Since listing in 1994, its shares have exhibited tremendous long-term capital appreciation.
Imagine we are a prudent investor with a long-term forward way of thinking. Next, imagine we invested $1,000 in CSL shares at the closing price of $28.39 per share back on 5 August 2011. That’s roughly 35 shares.
The first way we need to examine our return is to calculate the capital gains on our shares. In doing so we realise a return on investment of 943%, which is quite handy given the broad index’s return.
CSL share price over last 10 years — now
Source: The Motley Fool
That implies our original position is now worth approximately $9,430. However, that ignores one half of the equation. We also need to factor in the effect of CSL’s dividend, in order to assess our total return.
The effect of CSL’s dividend
Over the course of our examination period, CSL has returned $17.90 per share to shareholders by way of its dividend.
CSL has grown its dividend payment at a compound annual growth rate (CAGR) of 5.3% since 2011.
However, taking out the significant down-step in 2021, it has grown its dividend at a CAGR of approximately 14% over the same period.
CSL dividend history
Source: The Motley Fool
Adding in CSL’s dividend schedule, our total return mushrooms to more than 1005% over the previous 10-year period. This implies our position is now worth $10,056.
Some very interesting outcomes arrive when we make a few tweaks to our calculations. Let’s assume we reinvested the dividends received to buy more CSL shares along the way.
Harnessing the value of this dividend reinvestment plan (DRIP) yields a total return of 1,124% on our original investment.
Therefore, it suggests long-term investing can have tremendous payoffs, if done correctly.
Several things to always remember when investing.
First, long-term investing can work. While past returns are no guarantee of future performance, the ASX 200 has risen 83% over the past 10 years.
Second, always complete due diligence and the necessary research before allocating hard-earned capital. Finally, risk management is paramount. Maintaining an investment with conviction over a long-term horizon can be a winning formula, as evidenced through the case of CSL shares.
Should you invest $1,000 in CSL right now?
Before you consider CSL , you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and CSL wasn’t one of them.
The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of May 24th 2021
How owning too much Afterpay (ASX:APT) was our biggest regret
It hasn’t been a great 2021 so far for the CSL (ASX:CSL) share price
FY 2021 results preview: Is the CSL (ASX:CSL) share price in the buy zone?
Here are 3 dipping ASX shares now ready to rally
The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.